Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: esld major surgical or invasive procedure: liver transplant history of present illness: 54 y.o. male with hcv cirrhosis and hcc s/p rfa. has had sinus infection over last two weeks for which he has been taking augmentin. does have slight chills and night sweats since the sinus infection. has had slight chills and night sweats since the sinus infection. has had urinary retention in the past and has difficulty starting stream. no dysuria. past medical history: etoh cirrhosis hypertension gerd lap chole h/o polysubstance abuse in 80s h/o etoh abuse, quit 2 yrs pta social history: h/o etoh, none x 2 years, no drug use, no tobacco lives with dtr family history: no h/o ca or liver dz physical exam: 98.1 62 137/78 18 94%ra wd/wn, comfortable, nad lungs cta bilat, slight crackles at base cor s1s2, rrr abd soft, +bs, slight tenderness to palp in rlq ext warm, well perfused neuro awake, alert, cooperative with exam, nl affect pertinent results: on admission: wbc-5.1 rbc-3.90* hgb-13.3* hct-36.9* mcv-95 mch-34.1* mchc-36.1* rdw-14.9 plt ct-105* pt-14.0* ptt-34.9 inr(pt)-1.2* fibrinogen-181 glucose-103 urean-21* creat-0.8 na-139 k-3.9 cl-103 hco3-27 angap-13 alt-54* ast-59* alkphos-108 totbili-0.4 albumin-4.3 calcium-9.4 phos-4.2 mg-2.0 on discharge wbc-8.2 rbc-3.07* hgb-10.2* hct-29.2* mcv-95 mch-33.3* mchc-35.0 rdw-16.6* plt ct-147* glucose-94 urean-16 creat-0.7 na-137 k-4.1 cl-101 hco3-29 angap-11 alt-241* ast-63* alkphos-297* totbili-1.1 albumin-3.0* calcium-8.3* phos-4.0 mg-1.4* hbsab-positive, fk506-10.7 brief hospital course: he underwent deceased donor liver transplant, piggyback technique with portal vein to portal vein anastomosis, proper hepatic artery to common hepatic artery anastomosis, common bile duct to common bile duct anastomosis on . surgeon was dr. . please see operative report for details. he received induction immunosuppression consisting of solumedrol and cellcept. his donor was hepatitis b core positive. during the anhepatic phase, he received hbig 10,000 units then 5000 units iv once a day on pod . hbsab levels remained greater than 450. lamivudine was also given qd. postop, he did well. u/s of liver on pod 0 showed patent vessels. he was extubated and transferred out of the sicu on pod 2. prograf started on pod 2. lfts trended down. diet was advanced without problems. the lateral jp was removed on pod 5. the medial jp was draining 275cc/day of serosanguinous fluid, this was removed prior to discharge on . the incision was well approximated, without redness, clean and dry. was consulted for hyperglycemia. insulin sliding scale and long acting insulin were started, to continue insulin therapy at home. pt cleared him for home. medications on admission: triamterene/hctz- 25/37.5, prilosec 20' discharge medications: 1. prednisone 20 mg tablet sig: one (1) tablet po daily (daily). 2. lamivudine 100 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*2* 3. pantoprazole 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po q24h (every 24 hours). 4. metoprolol tartrate 25 mg tablet sig: one (1) tablet po bid (2 times a day). 5. fluconazole 200 mg tablet sig: two (2) tablet po q24h (every 24 hours). 6. valganciclovir 450 mg tablet sig: two (2) tablet po daily (daily). 7. trimethoprim-sulfamethoxazole 80-400 mg tablet sig: ten (10) ml po daily (daily). 8. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). 9. mycophenolate mofetil 250 mg capsule sig: four (4) capsule po bid (2 times a day). 10. hydromorphone 2 mg tablet sig: 1-2 tablets po q4-6h (every 4 to 6 hours) as needed for pain. disp:*30 tablet(s)* refills:*0* 11. insulin nph human recomb 100 unit/ml suspension sig: eight (8) units subcutaneous once a day. 12. insulin nph human recomb 100 unit/ml suspension sig: four (4) units subcutaneous at bedtime. disp:*1 bottle* refills:*2* 13. insulin lispro (human) 100 unit/ml solution sig: follow sliding scale subcutaneous four times a day. disp:*1 bottle* refills:*1* 14. syringes insulin syringes 1 box refill:1 15. other test strips 1 box refill:2 16. lancets 1 box refill:1 17. kayexalate powder sig: thirty (30) grams po per instructions from transplant office for elevated potassium. disp:*4 doses* refills:*2* 18. mycophenolate mofetil 500 mg tablet sig: two (2) tablet po bid (2 times a day). 19. tacrolimus 1 mg capsule sig: six (6) capsule po twice a day. discharge disposition: home discharge diagnosis: hcv/hcc cirrhosis discharge condition: good discharge instructions: please call transplant office if fevers, chills, nausea, vomiting, inability to take medications, incision redness/bleeding/drainage, jaundice or any questions shower, pat incision dry labs every monday and thursday. followup instructions: , md phone: date/time: 3:20 , md phone: date/time: 10:20 provider: , transplant social work date/time: 11:00 cat scan phone: date/time: 10:30 procedure: other transplant of liver transfusion of other serum transfusion of platelets injection or infusion of immunoglobulin transfusion of coagulation factors other operations on lacrimal gland transplant from cadaver diagnoses: esophageal reflux unspecified essential hypertension other specified disorders of pancreatic internal secretion adrenal cortical steroids causing adverse effects in therapeutic use cirrhosis of liver without mention of alcohol chronic hepatitis c without mention of hepatic coma personal history of tobacco use malignant neoplasm of liver, primary personal history of alcoholism 

Answer: The patient is high likely exposed to